drugset
Drugs / D759
last change Oct 2023 re-read 9 days ago

D759

Investigated by
Chong Kun Dang Pharmaceutical

Trials 12

today NCT05928637 · Ph 1 NCT05952219 · Ph 1 NCT05719155 · Ph 1 NCT05452525 · Ph 1 NCT05347576 · Ph 1 NCT05113693 · Ph 1 NCT04768673 · Ph 1 NCT04706286 · Ph 1 NCT04431687 · Ph 1 NCT04260438 · Ph 1 NCT04322032 · Ph 1 NCT04246190 · Ph 1
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 112 trials
Phase 1 NCT05928637 Jul → Aug 2023 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05952219 Jun 2023 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Unknown No outcome recorded
Phase 1 NCT05719155 Feb → Mar 2023 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05452525 Jul → Aug 2022 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05347576 Apr → May 2022 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT05113693 Nov → Dec 2021 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04768673 Mar → Apr 2021 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04706286 Feb → Mar 2021 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Unknown No outcome recorded
Phase 1 NCT04431687 Jun → Jul 2020 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04260438 Apr → Jun 2020 type 2 diabetes mellitus Chong Kun Dang Pharmaceutical Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 12 sources stand behind the page.

FieldValueCited text
Known as D759 “D759 Tab. 1 Tab. and D308 Tab. 1 Tab.(Total 2 Tab.), Single oral administration under fasting condition.” NCT04322032 ↗
11

NCT05452525 ↗

NCT04260438 ↗

NCT05347576 ↗

NCT05719155 ↗

NCT05928637 ↗

NCT05952219 ↗

NCT04706286 ↗

NCT05113693 ↗

NCT04246190 ↗

NCT04768673 ↗

Show 1 more source
Route Oral “Reference drug, CKD-501 1T and D759 1T, QD, PO” NCT04246190 ↗